Johns Hopkins researchers recommend reclassifying magic mushrooms from schedule I to IV drug

[Shuck]

And despite that, from what I read, the UK is actually better than the US when it comes to evidence-based drugs policy. It’s not particularly evidence-based, but yet it’s still better.